Amplia Therapeutics Limited INNMF OTC

Other OTC • Healthcare • Biotechnology • AU • USD

SharesGrow Score

32/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Amplia Therapeutics Limited (INNMF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 30/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

32/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

35/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — INNMF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio7.47

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.02

Book Value / Share$0.00

Revenue / Share$0.01

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-0.25	$0.00	$-4.94M	-
2017	$-0.30	$0.00	$-7.08M	-
2018	$-0.17	$0.00	$-4.3M	-
2019	$-0.04	$0.00	$-1.87M	-
2020	$-0.04	$34.23K	$-2.22M	-6483.2%
2021	$-0.02	$1.53M	$-2.28M	-148.7%
2022	$-0.03	$1.98M	$-3.64M	-183.7%
2023	$-0.03	$1.19M	$-6.24M	-524.8%
2024	$-0.02	$0.00	$-4.5M	-
2025	$-0.02	$3.78M	$-6.57M	-173.7%